Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Revance Therapeutics Inc. buy BiotechBee

Revance Therapeutics Inc.
Start price
€17.50
03.01.23 / 70%
Target price
€30.00
31.12.25
Performance (%)
76.00%
End price
€30.80
05.05.23
Summary
This prediction ended on 05.05.23 with a price of €30.80. With a performance of 76.00% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Revance Therapeutics Inc. - - - -
iShares Core DAX® 2.591% 2.691% 6.411% 53.612%
iShares Nasdaq 100 -0.915% -7.368% 20.651% 72.782%
iShares Nikkei 225® 0.145% -10.196% 46.169% 62.432%
iShares S&P 500 -0.367% -0.833% 18.019% 60.744%

According to BiotechBee what are the pros and cons of Revance Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Revance Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 76.00%
Target price 30.000
Change
Ends at 31.12.25

Buy mit Kursziel 30,0

BiotechBee 
0
Report Share
03.01.23
In the thread Trading Revance Therapeutics Inc.
Prediction Buy
Perf. (%) 76.00%
Target price 30.000
Change
Ends at 31.12.25

Buy beendet

BiotechBee 
0
Report Share
05.05.23